A systematic comparative study on the binding of anticancer drug irinotecan (Irino) with dsDNA and ssDNA was investigated in phosphate buffer solutions using voltammetric and spectroscopic methods. The decrease of the peak current of Irino was proportional to DNA concentration, which was applied for determination of dsDNA and ssDNA concentration. The achieved limits of detection of dsDNA and ssDNA were 5.49 Â 10 À7 and 1.87 Â 10 À7 M, respectively.
Introduction
Transcription and replication are vital to cell survival and proliferation as well as for smooth functioning of all body processes. DNA starts transcribing or replicating only when it receives a signal, which is oen in the form of a regulatory protein binding to a particular region of the DNA.
1 Thus, if the binding specicity and strength of this regulatory protein can be mimicked by a small molecule, then DNA function can be articially modulated, inhibited or activated by binding this molecule instead of the protein. Thus, synthetic/natural small molecules can act as a drug when activation or inhibition of DNA function is required to cure or control a disease. In recent years increased attention has been focused on the ways in which anticancer drugs interact with biological systems, with the goal of understanding the toxic as well as chemotherapeutic effects of those small molecules. 2 In this context there are primarily three different ways by which anticancer drugs interact with DNA: (i) through control of transcription factors and polymerases. Here, the drugs interact with proteins that bind to DNA; (ii) through RNA binding to the DNA double helix to form nucleic triple helix structures or RNA hybridization to exposed DNA single strand forming DNA-RNA hybrids that may interfere with transcriptional activity; and (iii) through binding of small aromatic ligand molecules to DNA double helical structures. The binding of small molecules to DNA involves electrostatic interaction, intercalation between base pairs and minor and major DNA grooves binding interaction. The interaction of some anticancer drugs with DNA has been studied by a variety of techniques including electrophoresis, 3, 4 X-ray crystallography, 5 structural modeling, 6 luminescence, 7 NMR, 8 resonance Rayleigh light scattering, 9 uorescence, 10-13 dynamic viscosity measurements, 14 high-performance liquid chromatography, 15 and UV-visible absorption spectroscopy. [16] [17] [18] [19] [20] [21] [22] [23] In recent years, there has been a growing interest in electrochemical investigation of interactions between anticancer drugs and other DNAtarget molecules and DNA. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] The use of electrochemical techniques to increase the knowledge of drug molecules and their mechanism of action is one of the most important phases of drug discovery. 37 On the other hand, the electrochemical DNA-biosensors form a useful model for simulating nucleic acid interactions with cell membranes, potential environmental carcinogenic compounds and clarifying the mechanism of interaction with drugs and chemotherapeutics. [38] [39] [40] However electrochemistry coupled with spectroscopy techniques could provide a relatively easy way to obtain useful insights into the molecular mechanism of drug-DNA interaction, which could be an important step in the development of a new anticancer drug. Among anticancer drugs, Irino has shown activity against colorectal, esophageal, gastric, non-small-cell and small-cell lung cancers, leukemia and lymphomas, as well as central nervous system malignant gliomas. 41 Irino interacts specically with DNA topoisomerase 1 (Topo 1). The formation of a cleavable drug-Topo1-DNA complex results in lethal doublestranded DNA breakage and cell death. 42 To the best our knowledge, no attention has been paid to a comparative study on the interaction of anticancer drug Irino with dsDNA and ssDNA. This investigation offers an opportunity to understand how the kind of DNA affects its binding and affinity of binding to the anticancer drug Irino.
In the present work, comparison of the mode interaction of Irino with dsDNA and ssDNA was investigated using voltammetric and spectroscopic methods. The formed anticancer Irino-dsDNA and Irino-ssDNA adducts at different temperatures leads to change in the thermodynamic and structural properties of DNA. The thermodynamic characterization of the drug binding might be used, together with structural studies, in development of new strategies to interface with gene expression in living cells. The present investigation offers also an opportunity to use Irino drug as a new electrochemical probe for determination of dsDNA and ssDNA concentrations.
Experimental

Instrumentation
Cyclic voltammetry (CV) and square wave voltammetry (SWV) were performed using an EG&G PAR 384 B (Princeton Applied Research, Oak Ridge, TN, USA) polarographic analyzer controlled by 394 soware in conjunction with a PAR Model 303A HMDE (Hanging Mercury Drop Electrode). The three electrode system was completed by an Ag/AgCl (saturated KCl) reference electrode and a Pt wire auxiliary electrode. A PAR Model 305 stirrer was used for the SWV. The ultraviolet and visible absorption spectra measurements were obtained using PerkinElmer (Lambda) spectrophotometer.
Chemicals and reagents
Calf thymus double stranded deoxyribonucleic acid (dsDNA) and irinotecan (Irino, for chemical structure see Scheme 1) were purchased from Sigma-Aldrich chemicals (St. Louis, Mo, USA) and were used as received without further purication. A stock standard solution of dsDNA was prepared by dissolving 0.1 g of dsDNA in 100 ml autoclaved deionized water and stored at 4 C and discarded aer no more than four days. The concentration of the stock solution of dsDNA (1.86 Â 10 À3 M in nucleotide phosphate, NP) was determined by UV absorbance at 260 nm using the molar extinction coefficient (3) at 6600 M À1 cm À1 .
Denatured single-stranded DNA was prepared by heating native double-stranded DNA in water bath at a 100 C for 30 min, followed by promptly cooling in ice bath. 43 The formation of ssDNA from dsDNA is checked by gel electrophoresis measurements. Images gel electrophoresis of ssDNA and dsDNA were provided in Fig. 1 
Voltammetric measurements
For voltammetric measurements, the test solution was placed in a polarographic cell of volume 10 ml and deoxygenated by bubbling nitrogen for 15 min. During measurements a steam of nitrogen was passed over the solution. SWV was performed using a pulse amplitude of 50 mVpp; a frequency of 120 Hz; a scan increment of 6 mV; an adsorption time of 60 s and equilibrium time of 15 s. CVs were recorded at a scan rate of 100 mV s À1 (unless otherwise stated). The peak potentials were reproducible to at least AE5 mV in the CVs and AE2 mV in the SWV. Concentrations of Irino and the total volume solution constant (5 ml) were kept constant while the concentrations of dsDNA and ssDNA were varied. The equilibrium binding constants and thermodynamic parameters for dsDNA-Irino and ssDNA-Irino complexes were determined at different temperatures. All experiments were carried out at 25 AE 0.05 C.
Scheme 1 Chemical structure of irinotecan. 
Results and discussion
Interaction of Irino with dsDNA
Cyclic voltammetric studies of Irino at a HMDE in phosphate buffer solutions showed only one cathodic peak corresponding to direct reduction of the lactone moiety of camptothecin to a lactol ring. 30 No anodic peaks were observed at any scan rate, indicating that the reduced form of Irino is electrochemically irreversible. The irreversible nature of the reduction process was conrmed by the shi of the peak potential (E P ) to a more negative value with the increase of the scan rate. The height of the reduction peak reached a maximum and the shape of the curve is better in PBS at pH 5.2. In this context the cathodic peak current of 38.5 mM Irino decreased at pH 5.2 more than at pH 7.2 upon the addition of 3.06 mM dsDNA (Fig. S1 †) . Therefore pH 5.2 was selected to study the interaction between Irino and ds-DNA. Under these conditions the dramatic changes of CV behavior of Irino in the presence of dsDNA should be occurred (Fig. 2 ). When dsDNA is added to a solution of Irino, the peak current height decreases and peak potential shis from À900 mV to more negative values À918 mV are observed. The peak potential of CV shis to more positive or negative values indicating that the action of Irino with dsDNA may be intercalation. 34, 36 Accordingly to these observations it seems that the decrease of peak current of Irino aer an addition of excess of dsDNA is caused by the intercalation of Irino to the bulk, slowly diffusing dsDNA, which results in considerable decrease in the apparent diffusion coefficient. This is emphasized from the decrease in the slope of linear Irino (in presence of 7.72 Â 10 À6 M dsDNA, NP). The changes in current upon addition of dsDNA can be explained in terms of diffusion of an equilibrium mixture free and bound Irino to the electrode and which can be used to quantify the binding of Irino to dsDNA. In this context, current titrations were performed by keeping the concentration of Irino constant while varying the concentration of dsDNA using SWV at pH 5.2. The current titration was described by the following eqn (1).
where K is the apparent binding constant, I G and I H-G are the peak current of the free guest (G) and the complex (H-G) respectively. Under the assumptions of irreversible, diffusioncontrolled electron transfer and a 1 : 1 association complex between the drug and dsDNA (in nucleotide phosphate), then the plot of log(1/[DNA]) versus log(I H-G /I G À I H-G ) becomes linear with the intercept of log K. The binding constant of this complex was evaluated according to eqn (1) and the result is cited in Table 1 . The value of K demonstrated that Irino binds to dsDNA with a high association constant. The change in Gibbs free energy for the Irino-dsDNA adduct was calculated from the well known relationship:
where the R is universal gas constant (8.31 J K À1 mol À1 ), T the absolute temperature and K the binding constant. The DG o values are negative, and increase negatively with increasing temperature, suggesting a thermodynamically favorable binding process. Ionic strength dependence of the interaction between Irino and dsDNA was also studied. When the ionic strength of the solution increased aer a salt was added, charge compensation of the nucleotide phosphates caused by cations would hinder the electrostatic binding effect. Consequently, complex formation through electrostatic binding would decrease, where the binding based on an intercalation mechanism should virtually unaffected. 44 The ionic strength of reaction medium was varied 
Spectral prole of the Irino-dsDNA complex
In order to validate the interaction between Irino and dsDNA, the UV-absorption spectra of Irino in the absence and presence of different concentrations of dsDNA were investigated. In the absence of dsDNA Irino has a sharp absorption peak at 255 nm and a broad absorption peak at 368 nm. When Irino and dsDNA are mixed, the spectrum is signicantly different from that of Irino or dsDNA (Fig. 3) . The absorption band at 255 nm showed increase in the peak intensity (hyperchromic effect) whereas the broad absorption band of Irino at 368 nm decreased slightly with successive additions of dsDNA. The hyperchromic effect may be due to intercalation of the Irino between the dsDNA base pairs. Intercalational phenomena of the Irino with dsDNA could be explained by the presence of two different electronic transitions, p-p* and n-p* of Irino spectra. The increase in the concentration of added dsDNA enhanced the absorption peak height i.e. hyperchromic effect (p-p* region) that could be related with enhanced intercalation of Irino into dsDNA and the complex formed accordingly may become more compact. 45 To conrm the mode of intercalation between the anticancer Irino and dsDNA, absorption spectra of Irino at a constant concentration (2 Â 10 À5 M) in the absence and presence of dsDNA are taken (Fig. 3A) . Absorbance maximum of dsDNA is located at 260 nm due to a consequence of the chromophoric groups in purine and pyrimidine moieties responsible for the electronic transitions. When the Irino interacts with dsDNA, it causes hyperchromic effect with increasing concentration of Irino in solution (Fig. 3B ). This increase in intensity of absorption maxima (hyperchromic effect) of drug or dsDNA binding molecules is a typical characteristic of dsDNA intercalation. 46 The increase in the absorbance intensity of dsDNA is attributed also to stacking interaction of drug chromophore with dsDNA bases. This was consistent with the result obtained by the electrochemical method.
Interaction of Irino with ssDNA
The interaction of the anticancer drug Irino with ssDNA was investigated by means of CV as shown in Fig. 4 . When ssDNA is added to a solution of Irino, marked decreases in the peak current heights are observed. The cathodic peak current of Irino decreased by ca. 71.1% in presence of 2.08 Â 10 À6 M ssDNA and the peak potential shied to more negative potential. Accordingly to these observations it seems that the decrease of peak current of Irino aer an addition of excess ssDNA is cased by the electrostatic attraction of Irino to the bulk, slowly dispersion ssDNA, which results in considerable decrease in the apparent diffusion coefficient. This is emphasized from the decrease in the slope of the linear i p À n log(I H-G /I G À I H-G ) is linear with the intercept of log K. Comparison of the interaction of Irino upon the addition of dsDNA and ssDNA at pH 5.2 indicated that the decrease in peak current (DI) decreases more sharply with the addition of ssDNA than in the presence of dsDNA as shown in Fig. 5 . In this context the apparent diffusion coefficient of the Irino-dsDNA adduct is smaller than that of the Irino-ssDNA complex. Furthermore, the binding constant of Irino-dsDNA adduct is lower than of the Irino-ssDNA adduct ( Table 1) . As the same the calculated DG o values for the binding process of Irino with ssDNA is more negative than of the interaction of Irino with dsDNA. This result indicates a different interaction mechanism of Irino with ssDNA than with dsDNA. The interaction of Irino with dsDNA might be attributed to its intercalation into base stacking domain of DNA double helix. The interaction of Irino with ssDNA indicated that the backbone of ssDNA is negatively charged and can easily attract to the investigated drug via electrostatic attraction. The results offer an opportunity to understand how the kind of DNA affects its binding and affinity of binding to anticancer drug Irino.
Thermodynamic parameters of Irino-dsDNA and IrinossDNA complexes
To have a better understanding of thermodynamics of the reaction between Irino and dsDNA, it is useful to determine the contributions of enthalpy and entropy of the reaction. In this context the integrated form of van't Hoff eqn (3) permits to calculate the values of enthalpy (DH o ) and entropy (DS o ) depending on variation of the stability constant with temperature.
The van't Hoff plots (Fig. 6) for the Irino-dsDNA adduct shows a linear behavior and allows to derive the thermodynamic parameters ( Table 1 ). The positive value of enthalpy change indicates that the interaction process of Irino with dsDNA is endothermic. Also the entropy associated with the complexation process is positive which indicates an increase in transitional and rotational degrees of freedom of the complexed molecular.
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Accordingly to the thermodynamic data, interpreted as follows, the model of interaction between a drug and biomolecule can be:
48 ( (Table 1) . Comparing the thermodynamic parameters for the interaction of anticancer Irino with dsDNA and ssDNA it is obvious that the interaction of Irino with ssDNA displaced high affinity in solution than that with dsDNA. The 
Determination of stoichiometric coefficient
As no new electrochemical signals appeared aer dsDNA Irino interaction, it would be possible to assume that only one complex is formed [dsDNA (Irino) n ], according to.
Thus, the binding constant is as follows:
where "n"is the molar relation of Irino that interacts with a molar quantity of dsDNA bases. Thus, on assessing the change in the current due to the presence of a constant concentration of dsDNA over different concentrations of Irino, the following eqn was used:
The plot of log[DI/(DI max À DI)] vs. log[Irino] becomes linear with the slope of "n" and the intercept of "n log b s ". Fig. 7A shows the effect of a constant dsDNA concentration on the electrochemical response of a series of Irino concentration solutions and Fig. 7B shows a linear logarithmic relation. The fact that there is one slope in plot represented in Fig. 7B conrms the single complex formation, thus the molar value of "n" and binding constant for dsDNA-Irino complex are determined. There is good agreement between K values of Irino-dsDNA obtained from eqn (1) and (6) optimum experimental conditions the decreases in peak current of Irino were linearly related to dsDNA or ssDNA concentrations in the range of 1.24 Â 10 À6 M to 3.33 Â 10 À7 M when the Irino concentration xed as at 3.85 Â 10 À5 M (Fig. 8) .
The variation of decrease in peak current versus the dsDNA or ssDNA concentration was represented by a straight line followed the equations I P (mA) ¼ 0. 46 
Conclusion
In this paper a systematic comparative study of the binding of anticancer Irino with dsDNA and ssDNA has been investigated. 
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